Skip to content

SLO-imaging for quantifying the efficacy of Nd:YAG-laser vitreolysis for disturbing vitreous floaters.

SLO-imaging for quantifying the efficacy of Nd:YAG-laser vitreolysis for disturbing vitreous floaters. - Vitreous floaters & SLO-imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42721
Enrollment
32
Registered
2015-05-29
Start date
2016-05-25
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitreous floaters

Interventions

None listed

Sponsors

Oogziekenhuis Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age >= 18 years. Informed consent. Floaters not adjacent to the lens or retina (> 2 mm). Complaints lasting > 3 months. Vitreous floaters are PVD related.

Exclusion criteria

Exclusion criteria: History of glaucoma, uveitis, macular degeneration, retinal defect (eye to be treated or fellow-eye), macular edema, vascular retinal disease. Other condition causing increased straylight, such as corneal haze, guttata, corneal surgery, refractive surgery, cataract affecting vision, PCO, contact lenses, iris diaphany, peripheral iridectomy/iridotomy.

Design outcomes

Primary

MeasureTime frame
Reduction of floater area measured on SLO-image at six months after first laser treatment.

Secondary

MeasureTime frame
Safety. Number of treatments (1, 2 or 3). Applied laser energy per treatment session. Visual acuity (logMAR). OCT: optic nerve and the macula (cystoid macular edema y/n). Intraocular pressure. Fundusphotograph. Peripheral retinal exam. Visual function questionnaire VFQ-25. Floater questionnaire (see Appendix).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)